Innovating Nanoethics

Nanotechnological developments include diagnostic devices, drug delivery vehicles, and therapeutic agents. These innovations have revolutionized how we think about disease diagnosis and treatment at the cellular level. This issue considers the roles of ethics in shaping legislation, organizational policy, and public discussion about nanomedicine. 

Volume 21, Number 4: E311-371 Full Issue PDF
  • From the Editor
    Apr 2019

    Innovating Nanoethics

    Linda Jiang and Kim A. Carmichael, MD
    Nanoscale materials used to diagnose, monitor, prevent, and treat disease have revolutionized how we think about disease etiology at atomic, molecular, and macromolecular levels. How should ethics respond?
    AMA J Ethics. 2019;21(4):E313-316. doi: 10.1001/amajethics.2019.313.
  • Medical Education
    Apr 2019

    Which Nanobasics Should Be Taught in Medical Schools?

    Joel C. Sunshine, MD, PhD and Amy S. Paller, MD, MSci
    Growth in nano-based approaches to cancer diagnostics and therapeutics creates need to include nanotoxicology in medical education.
    AMA J Ethics. 2019;21(4):E337-346. doi: 10.1001/amajethics.2019.337.
  • Health Law
    Apr 2019

    Regulating Nanomedicine at the Food and Drug Administration

    Jordan Paradise, JD
    Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.
    AMA J Ethics. 2019;21(4):E347-355. doi: 10.1001/amajethics.2019.347.
  • Art of Medicine
    Apr 2019

    Journeys

    Madeleine Schachter, JD
    Patients’ experiences of darkness and doubt can be replaced by a sense of buoyancy and lightness. Color and movement convey a patient’s sense of striving, aspiration, and optimism.
    AMA J Ethics. 2019;21(4):E370-371. doi: 10.1001/amajethics.2019.370.